At a glance
- Originator Bristol-Myers Squibb
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 04 Sep 1998 No-Development-Reported for HIV-1 infections in USA (PO)
- 26 Oct 1995 Preclinical development for HIV-1 infections in USA (PO)